Home About CDC Newsroom Funding A-Z Index CDC Organization Training & Education Contact Us
CDC Centers for Disease Control and Prevention Home Page
_
_  
Search: 
 
_
_
vCJD (Variant Creutzfeldt-Jakob Disease)

Diagnostic Criteria for Variant Creutzfeldt-Jakob Disease in the United States

Definite Variant CJD

Neuropathologic examination of brain tissue is required to confirm a diagnosis of variant CJD. The following confirmatory features should be present.

  • Numerous widespread kuru-type amyloid plaques surrounded by vacuoles in both the cerebellum and cerebrum - florid plaques.
  • Spongiform change and extensive prion protein deposition shown by immunohistochemistry throughout the cerebellum and cerebrum.

Suspected Variant CJD

  • Current age or age at death <55 years (a brain autopsy is recommended, however, for all physician-diagnosed CJD cases).
  • Psychiatric symptoms at illness onset and/or persistent painful sensory symptoms (frank pain and/or dysesthesia).
  • Dementia, and development ≥4 months after illness onset of at least two of the following five neurologic signs: poor coordination, myoclonus, chorea, hyperreflexia, or visual signs. (If persistent painful sensory symptoms exist, ≥4 months delay in the development of the neurologic signs is not required).
  • A normal or an abnormal EEG, but not the diagnostic EEG changes often seen in classic CJD.
  • Duration of illness of over 6 months.
  • Routine investigations of the patient do not suggest an alternative, non-CJD diagnosis.
  • No history of receipt of cadaveric human pituitary growth hormone or a dura mater graft.
  • No history of CJD in a first degree relative or prion protein gene mutation in the patient.

NOTE:

  1. If a patient has the typical bilateral pulvinar high signal on MRI scan, a suspected diagnosis of variant CJD requires the presence of a progressive neuropsychiatric disorder, d, e, f and g of the above criteria, and four of the following five criteria: 1) early psychiatric symptoms (anxiety, apathy, delusions, depression, withdrawal); 2) persistent painful sensory symptoms (frank pain and/or dysesthesia); 3) ataxia; 4) myoclonus or chorea or dystonia; and 5) dementia.
  2. A history of possible exposure to bovine spongiform encephalopathy (BSE) such as residence or travel to a BSE-affected country after 1980 increases the index of suspicion for a variant CJD diagnosis.

Download the printer-friendly PDF version [PDF - 50 KB].

 
 
Date: August 23, 2010
Content source: Centers for Disease Control and Prevention
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Division of High-Consequence Pathogens and Pathology (DHCPP)
_
Program Contents
bullet Topic Home
bullet Diagnostic Criteria
bullet Questions and Answers: BSE and vCJD
bullet Fact Sheet: vCJD
bullet Epidemiology
bullet Risk for Travelers
bullet Prevention
bullet Treatment
  bullet News Archive
  bullet References and Resources
Related Topics

Prion Diseases

Bovine spongiform encephalopathy

Chronic Wasting Disease (CWD)

Creutzfeldt-Jakob Disease (CJD)

Contact CDC

  • Centers for Disease Control and Prevention
    National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
    Division of High-Consequence Pathogens and Pathology (DHCPP)


    1 (800) CDC-INFO (232-4636)
    TTY: 1 (888) 232-6348

    E-mail:
    prion@cdc.gov

 
    Home   |   Policies and Regulations   |   Disclaimer   |   e-Government   |  FOIA   |  Contact Us  
Safer, Healthier People USAGovDHHS Department of Health
and Human Services
Centers for Disease Control and Prevention,1600 Clifton Rd, Atlanta, GA 30333, U.S.A
Tel: (404) 639-3311 / Public Inquiries: (404) 639-3534 / (800) 311-3435